| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jul―21 |
Synthesis and Inhibitory Assessment of ACE2 Inhibitors for SARS-CoV-2: An In Silico and In Vitro Study |
Xiaoyun Wang, Jieyu He, Layla Hosseini-Gerami, Morgan Thomas, Stephen Thompson, Joseph Ford, et al. (+6) Sebastiano Ortalli, Zijun Chen, Gianluca Destro, Andreas Bender, Franklin Aigbirhio, Véronique Gouverneur |
| 2 |
[GO] |
2023―Aug―22 |
Multicomponent Synthesis of the SARS-CoV-2 Main Protease Inhibitor Nirmatrelvir |
H. Daniel Preschel, Ruben T. Otte, Ying Zhuo, Rebecca E. Ruscoe, Ashleigh J. Burke, Rachel Kellerhals, et al. (+6) Brendan Horst, Sven Hennig, Elwin Janssen, Anthony P. Green, Nicholas J. Turner, Eelco Ruijter |
| 3 |
[GO] |
2023―Jan―09 |
DDQ/Fe(NO3)3-Catalyzed Aerobic Synthesis of 3-Acyl Indoles and an In Silico Study for the Binding Affinity of N-Tosyl-3-acyl Indoles toward RdRp against SARS-CoV-2 |
Gopal Rana, Abhishek Kar, Sandip Kundal, Dulal Musib, Umasish Jana |
| 4 |
[GO] |
2022―Aug―30 |
Peptidomimetic Small-Molecule Inhibitors of 3CLPro Activity and Spike-ACE2 Interaction: Toward Dual-Action Molecules against Coronavirus Infections |
Filomena Tedesco, Lorenzo Calugi, Elena Lenci, Andrea Trabocchi |
| 5 |
[GO] |
2022―Feb―28 |
Pyrido[1,2-e]purine: Design and Synthesis of Appropriate Inhibitory Candidates against the Main Protease of COVID-19 |
Parvin Moghimi, Hossein Sabet-Sarvestani, Omid Kohandel, Ali Shiri |
| 6 |
[GO] |
2021―Aug―28 |
Improved Synthesis of a Cyclic Glutamine Analogue Used in Antiviral Agents Targeting 3C and 3CL Proteases Including SARS-CoV-2 Mpro |
Wayne Vuong, John C. Vederas |
|
